NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 138 filers reported holding NEVRO CORP in Q3 2023. The put-call ratio across all filers is 2.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $40,710,000 | +18.9% | 562,833 | +33.3% | 4.84% | +1.5% |
| Q4 2021 | $34,233,000 | -27.1% | 422,260 | +4.7% | 4.77% | -29.2% |
| Q3 2021 | $46,950,000 | +0.2% | 403,424 | +42.7% | 6.74% | +39.6% |
| Q2 2021 | $46,856,000 | +86.6% | 282,620 | +57.0% | 4.83% | +51.1% |
| Q1 2021 | $25,110,000 | -14.0% | 180,000 | +6.7% | 3.19% | -15.7% |
| Q4 2020 | $29,213,000 | +31.1% | 168,761 | +5.5% | 3.79% | -24.0% |
| Q3 2020 | $22,288,000 | +24.0% | 160,000 | +6.3% | 4.98% | +10.0% |
| Q2 2020 | $17,978,000 | +28.4% | 150,485 | +7.5% | 4.53% | -16.4% |
| Q1 2020 | $13,997,000 | +33.3% | 140,000 | +56.7% | 5.41% | +94.5% |
| Q4 2019 | $10,500,000 | – | 89,333 | – | 2.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |